WS
TMDX icon

Wedbush Securities’s Transmedics TMDX Stock Holding History

Wedbush Securities’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,428
Closed -$459K – 1257
2025
Q2 		$459K Buy
3,428
+79
+2% +$8.67K 0.02% 667
2025
Q1 		$225K Sell
3,349
-79
-2% -$5.43K 0.01% 958
2024
Q4 		$214K Sell
3,428
-249
-7% -$23.2K 0.01% 997
2024
Q3 		$577K Buy
3,677
+954
+35% +$147K 0.02% 556
2024
Q2 		$410K Sell
2,723
-11,306
-81% -$1.36M 0.01% 704
2024
Q1 		$1.04M Buy
+14,029
New +$1.16M 0.04% 373

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wedbush Securities's TMDX Position: Q3 2025 in Review

Wedbush Securities sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 3,428 shares — an estimated $459K sold.

Wedbush Securities first reported a position in TMDX in Q1 2024 and held it in 6 quarters. The position peaked at $1.04M in Q1 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Wedbush Securities reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • Wedbush Securities sold 3,428 Transmedics shares in Q3 2025, an estimated $459K.
  • Wedbush Securities first reported a position in Transmedics in Q1 2024 and held it in 6 quarters.
  • Wedbush Securities's Transmedics position peaked at $1.04M in Q1 2024.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Wedbush Securities's 13F filing for Q3 2025, filed 6 Nov 2025.